America is still the world leader in creating new medical technologies that have the potential to save lives. So why is it so tough for the entrepreneurs and investors behind these new products to make a living here?
One reason, according to venture capitalists, is long, costly delays before getting new treatments to market, in some cases caused by health insurers dragging their feet when it comes to agreeing to reimburse doctors for using new medical products.
{iframe}http://blogs.wsj.com/venturecapital/2014/06/13/vc-asks-congress-for-new-medicare-policy-to-help-medical-tech-startups/{/iframe}